Hims & Hers Health, Inc.

HIMSNYSEUSD
32.71 USD
0.01 (0.03%)AT CLOSE (11:59 AM EDT)
32.41
0.30 (0.92%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
32.41
0.30 (0.92%)
🔴Market: CLOSED

HIMS is currently priced at $32.39. HIMS shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation front, HIMS trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Jun 25, 2026.

Open?$33.41
High?$33.45
Low?$30.29
Prev. Close?$32.70
Volume?15.1M
Avg. Volume?20.9M
VWAP?$31.36
Rel. Volume?0.72x
Bid / Ask
Bid?$32.12 × 100
Ask?$32.70 × 300
Spread?$0.58
Midpoint?$32.41
Valuation & Ratios
Market Cap?7.6B
Shares Out?223.1M
Float?194.6M
Float %?87.4%
P/E Ratio?N/A
P/B Ratio?16.96
EPS?-$0.06
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
Employees
2.4K
Market Cap
7.6B
Industry
SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE
Listed
2021-01-21
Address
2269 CHESTNUT ST
SAN FRANCISCO, CA 94123
Phone: 415-851-0195
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+1/3)
Medium-Term (Wave)? Bullish(+3/3)
Short-Term (Ripple)? Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
99
Momentum?
5
Short Sent.?
42
Piotroski F-Score?2/9Weak
Altman Z-Score?5.21Safe
Confidence?55%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?33.64%Squeeze Risk
Short Interest?65.5M
Days to Cover?3.5
Free Float194.6M
Avg Daily Volume18.6M
Settlement Date2026-06-15
Financial Health
Current Ratio?1.69Adequate
Quick Ratio?1.56Adequate
Cash Ratio?0.36Low
Debt/Equity?2.18High
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score
47/100
P/E?
N/A
P/B?
Peers
100
S&P
10
16.96HIGH
P/S?
Peers
100
S&P
48
3.19FAIR
P/FCF?
Peers
100
S&P
3
113.2PRICEY
EV/EBITDA?
Peers
100
S&P
3
221.5HIGH
EV/Sales?
Peers
100
S&P
54
3.51FAIR
Returns & Efficiency
ROE?
S&P
13
-3.0%WEAK
ROA?
S&P
6
-0.6%WEAK
Cash Flow & Enterprise
FCF?$66.9M
Enterprise Value?$8.3B
Fundamentals ratios updated end of day